← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Tumori (ISSN 0300-8916, 2038-2529) is a journal published by Wichtig Publishing Srl in Italy. It covers Biochemistry, Genetics and Molecular Biology, Medicine and Medicine (miscellaneous). It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 2, Scopus Q3, Web of Science Q4, CiteScore 4 and HEC W-Category. Article processing charge: USD 4,150. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.

Journal title

Tumori

ISSN
0300-8916, 2038-2529
Subject area
BiochemistryGenetics and Molecular BiologyMedicineMedicine (miscellaneous)Cancer ResearchOncology
Indexed
ScopusWeb of ScienceMEDLINEPubMedHEC
Scopus Quartile
Q3
WoS Quartile
Q4
Impact Factor
2
Country
Italy
Publisher
Wichtig Publishing Srl
SJR
0.574
Open access
No
APC (USD)
4150
About the journal
Tumori is a journal published by Wichtig Publishing Srl (Italy). Topics: cancer research, oncology.
Aims and Scope
Tumori Journal is an international peer-reviewed journal that publishes the most innovative results in cancer research and treatment. It aims to share with the scientific community experiences of excellence that cover all aspects of oncology science. The journal encourages the submission of original data on cancer biology and therapy, technological innovation for precision oncology, and clinical trials.
SCImago Ranking
10330
HEC
W-Category
Journal Website
www.istitutotumori.mi.it/en/tumori-journal ↗
Registered In
1946
Instructions for Authors URL
journals.sagepub.com/author-instructions/TMJ ↗
Average Time To Publication After Submission (In Weeks)
—
APC Information URL
—
Waiver policy
—
Scopus URL
www.scopus.com/sourceid/13175 ↗
Scopus Cite Score
4
WoS Status
Science Citation Index Expanded (SCIE)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Tumori

Is Tumori HEC recognised?

Yes. The catalogue records Tumori in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Tumori indexed in Scopus?

Yes. Tumori is listed as Scopus-indexed, in quartile Q3, with a CiteScore of 4. Check its current status on the Scopus Sources page.

Is Tumori in Web of Science?

Yes. Tumori is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q4. Confirm on Clarivate's Master Journal List.

What is the impact factor of Tumori?

The recorded journal impact factor of Tumori is 2. Clarivate updates impact factors every year in Journal Citation Reports.

Is Tumori open access, and what does it charge?

Tumori is not recorded as fully open access and its APC is USD 4,150. Fees change, so check the journal's website before you submit.

Who publishes Tumori?

Tumori is published by Wichtig Publishing Srl in Italy, under ISSN 0300-8916 and 2038-2529.

Research profile

Main research topics: Breast Cancer Treatment Studies, Breast Lesions and Carcinomas, Head and Neck Cancer Studies, Lymphoma Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Sarcoma Diagnosis and Treatment.

Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal